Thyrotropin-secreting pituitary tumors: Diagnostic criteria, thyroid hormone sensitivity, and treatment outcome in 25 patients followed at the National Institutes of Health

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 2, 1999, Pages 476-486

  Brucker Davis, Françoise ^a   Oldfield, Edward H ^a   Skarulis, Monica C ^a   Doppman, John L ^a   Weintraub, Bruce D ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; OCTREOTIDE; PROTIRELIN; THYROID HORMONE; THYROTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; HEALTH CARE ORGANIZATION; HORMONE SENSITIVITY; HUMAN; HYPERTHYROIDISM; HYPOPHYSIS ADENOMA; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; THYROTROPIN RELEASE; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

EID: 0032976979     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.84.2.5505     Document Type: Article

References (42)

1. 1. Beck-Peccoz P, Brucker-Davis F, Persani L, Smallridge RC, Weintraub BD. 1996 Thyrotropin-secreting pituitary tumors. Endocr Rev. 17:610-638.
2. 2. Samuels MH, Ridgway EC. 1995 Glycoprotein-secreting pituitary adenomas. Bailliere Clin Endocrinol. 9:337-358.
3. 3. Greenman Y, Melmed S. 1995 Thyrotropin-secreting pituitary tumors. In: Melmed S, ed. The pituitary. Boston: Blackwell; 546-558.
4. 4. Weintraub BD, Gershengorn MC, Kourides IA, Fein H. 1981 Inappropriate secretion of thyroid-stimulating hormone. Ann Intern Med. 95:339-351.
5. 5. Faglia G, Beck-Peccoz P, Piscitelli G, Medri G. 1987 Inappropriate secretion of thyrotropin by the pituitary. Horm Res. 26:79-99.
6. 6. Refetoff S, Weiss RE, Usala SJ. 1993 The syndromes of resistance to thyroid hormone. Endocr Rev. 14:348-399.
7. s, or thyrotropin-releasing hormone receptor genes. J Clin Endocrinol Metab. 81:1134-1140.
8. 8 Mantovani S, Beck-Peccoz P, Saccomanno K, Spada A, Faglia G, Barbetti F. TSH-secreting pituitary adenomas are monoclonal in origin [Abstract P2-485]. Proc of the 77th Annual Meet of The Endocrine Soc. 1995; 412.
9. 9. Gesundheit N, Petrick P, Nissim M, et al. 1989. Thyrotropin-secreting pituitary adenomas: clinical and biochemical heterogeneity. Ann Intern Med. 111:827-835.
10. 10. Mixson AJ, Friedman TC, David AK, et al. 1993 Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab. 76:529-533.
11. 11. McCutcheon IE, Weintraub BD, Oldfield EH. 1990 Surgical treatment of thyrotropin-secreting pituitary adenomas. J Neurosurg. 73:674-683.
12. 12. Brucker-Davis F, Skarulis MC, Grace MB, et al. 1995 Genetic and clinical features of 42 kindreds with RTH. The NIH prospective study. Ann Intern Med. 123:572-583.
13. 13. Beck-Peccoz P, Mariotti S, Guillausseau J, et al. 1989 Treatment of hyperthyroidism due to inappropriate secretion of thyrotropin with the somatostatin analog SMS 201-995. J Clin Endocrinol Metab. 68:208-214.
14. 3CT) [Abstract P1-396]. Proc of the 77th Annual Meet of The Endocrine Soc. 1995; 211.
15. 15. Kourides IA, Ridgway EC, Weintraub BD, Bigos ST, Gershengorn MC, Maloof F. 1977 Thyrotropin-induced hyperthyroidism: use of α and β subunit levels to identify patients with primary tumors. J Clin Endocrinol Metab. 45:534-543.
16. 16. Beck-Peccoz P, Persani L, Faglia G. 1992 Glycoprotein hormone α-subunit in pituitary adenomas. Trends Endocrinol Metab. 3:41-45.
17. 17. Mindermann T, Wilson CB. 1993 Thyrotropin-producing pituitary adenomas. J Neurosurg. 79:521-527.
18. 18. Azukizawa M, Morimoto S, Miyai K, et al. 1980 TSH-producing pituitary adenoma associated with Graves' disease. In: Stockigt JR, Nagataki S (eds) Thyroid research. Canberra: Australian Academy of Sciences; vol 8:645-648.
19. 19. Frandsen NJ, Transbol I. 1991 Coexisting Graves' disease and TSH-producing pituitary adenoma. Ugeskr Laeger. 153:854-855.
20. 20. Kamoi K, Mitsuma T, Sato H, et al. 1985 Hyperthyroidism caused by a pituitary thyrotropin-secreting tumour with excessive secretion of thyrotropin-releasing hormone and subsequently followed by Graves' disease in a middle-aged woman. Acta Endocrinol (Copenh). 110:373-382.
21. 21. Hall WA, Luciano MG, Doppman JL, Patronas NJ, Oldfield EH. 1994 Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med. 120:817-820.
22. 22. Watanabe K, Kameya T, Yamauchi A, et al. 1993 Thyrotropin-producing adenoma associated with pituitary resistance to thyroid hormone. J Clin Endocrinol Metab. 76:1025-1030.
23. 23. Beck-Peccoz P, Persani L. 1994 Variable biological activity of thyroid-stimulating hormone. Eur J Endocrinol. 131:331-340.
24. 24. Chanson P, Li JY, LeDafniet M, et al. 1988 Absence of receptors for thyrotropin (TSH)-releasing hormone in human TSH-secreting pituitary adenomas associated with hyperthyroidism. J Clin Endocrinol Metab. 66:447-450.
25. 25 LeDafniet M, Brandi A-M, Kujas M, Chanson P, Peillon F. 1994 Thyrotropin-releasing hormone (TRH) binding sites and thyrotropin response to TRH are regulated by thyroid hormones in human thyrotropic adenomas. Eur J Endocrinol. 130:559-564.
26. 26. Bertherat J, Brue T, Enjalbert A, et al. 1992 Somatostatin receptors on thyrotropin-secreting pituitary adenomas: comparison with the inhibitory effects of octreotide upon in vivo and in vitro hormonal secretions. J Clin Endocrinol Metab. 75:540-546.
27. 27. Takano K, Ajima M, Teramoto A, Hata K, Yamashita N. 1995 Mechanisms of action of somatostatin on human TSH-secreting adenoma cells. Am J Physiol. 268:E558-E564.
28. 28. Beck-Peccoz P, Roncoroni R, Mariotti S, et al. 1990 Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary resistance to thyroid hormone in non neoplastic IST. J Clin Endocrinol Metab. 71:19-25.
29. 29. Ezzat S, Horvath E, Kovacs K, Smyth HS, Singer W, Asa SL. 1995 Basic fibroblast growth factor expression by two prolactin and thyrotropin-producing pituitary adenomas. Endocr Pathol. 6:125-134.
30. 30. Olson BR, Rubino D, Gumowski J, Oldfield EH. 1995 Isolated hyponatremia after transspenoidal surgery. J Clin Endocrinol Metab. 80:85-91.
31. 31. Wood DF, Johnston JM, Johnston DG. 1991 Dopamine, the dopamine D2 receptor and pituitary tumours. Clin Endocrinol (Oxf). 35:455-466.
32. 32. Francis TB, Smallridge RC, Kane J, Magner JA. 1993 Octreotide changes serum thyrotropin (TSH) glycoisomer distribution as assessed by lectin chromatography in a TSH macroadenoma patient. J Clin Endocrinol Metab. 77:183-187.
33. 33. Greenman Y, Melmed S. 1994 Expression of three somatostatin receptor subtypes in pituitary adenomas: evidence for preferential SSTR5 expression in the mammosomatotroph lineage. J Clin Endocrinol Metab. 79:724-729.
34. 34. Comi R, Gesundheit N, Murray L, Gorden P, Weintraub BD. 1987 Response of thyrotropin-secreting pituitary adenomas to a long-acting somatostatin analogue. N Engl J Med. 317:12-17.
35. 35. Chanson P, Weintraub BD, Harris AG. 1993 Octreotide therapy for thyroid stimulating secreting pituitary adenomas. A follow-up of 52 patients. Ann Intern Med. 119:236-240.
36. 36. Gancel A, Vuillermet P, Legrand A, Catus F, Thomas F, Kuhn JM. 1994 Effets of a slow-release formulation of the new somatostatin analogue lanreotide in TSH-secreting pituitary adenomas. Clin Endocrinol (Oxf). 40:421-428.
37. 3-receptor mRNA levels and growth of thyrotropic tumors. Mol Cell Endocrinol. 91:75-81.
38. 38. Selman WR, Laws ER Jr, Scheithauer BW, Carpenter SM. 1986 The occurrence of dura invasion in pituitary adenomas. J Neurosurg. 64:402-407.
39. 39. Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P. 1996 Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas. J Clin Endocrinol Metab. 81:3084-3090.
40. 40. Beckers A, Abs R, Mahler C, et al. 1991 Thyrotropin-secreting pituitary adenomas: report of seven cases. J Clin Endocrinol Metab. 72:477-483.
41. 41. Grisoli F, Leclercq T, Winteler JP, et al. 1986 Thyroid-stimulating hormone pituitary adenomas and hyperthyroidism. Surg Neurol. 25:361-368.
42. 42. Stefaneanu L, Kovacs K, Horvath E, et al. 1994 In situ hybridization study of estrogen receptor messenger ribonucleic acid in human adenohypophysial cells and pituitary adenomas. J Clin Endocrinol Metab. 78:83-88.